Through our specialized Neolife oncology division established in 2010, RPG Life Sciences provides high-potency targeted therapies and supportive chemotherapeutic formulations for solid tumors and hematological malignancies, prioritizing efficacy, precision, and patient adherence.
Imatinib Mesylate Tablets (100mg, 400mg)
Capecitabine Tablets (500mg)
Anastrozole Tablets (1mg)